Innovent's IBI363 receives third Chinese regulatory BTD for MSS/pMMR CRC

Rznomics receives FDA RMAT designation for HCC candidate RZ‑001

Halozyme and GSK sign global drug‑delivery collaboration

Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma

Diakonos Oncology's DOC1021 granted US FDA Fast Track Designation for unresectable or metastatic cutaneous melanoma

Racura Oncology identifies mechanism of action for (E,E)-bisantrene

ZYUS Life Sciences receives second US pain management patent

Citius Oncology to accelerate LYMPHIR commercialisation with up to USD36.5m in debt and equity capital

Photocure study supports cost-effectiveness of blue light cystoscopy

Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review

FDB introduces gravimetric content to improve IV medication compounding

Curocell secures full approval for RIMQARTO to enter CAR-T therapy market

European Commission clears first pertuzumab biosimilar in Europe

C-Ray Therapeutics' Copper-64 (Cu-64) Type II DMF gains FDA acceptance

GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation